Otimização das rotas sintéticas do molnupiravir e de intermediários do remdesivir no contexto da farmacoterapia anti-Covid-19
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
The Covid-19 viral infection pandemic represented one of the greatest health challenges ever
recorded, whose impacts extended beyond the sphere of public health and triggered a global
socioeconomic recession. Although population-wide vaccination helped contain the spread of
the disease, factors such as the persistence of vulnerable individuals and the risk of emerging
variants of SARS-CoV-2, its etiological agent, underscored the need for safe, accessible, and
readily available pharmacotherapies to complement immunization strategies. To this end, given
the high costs and long timelines associated with developing new bioactive molecules,
investigating the clinical efficacy of existing drugs emerged as a viable alternative, culminating
in the approval of the antivirals molnupiravir and remdesivir for the emergency treatment of
Covid-19 in several countries, including Brazil. In this context, the present work aimed to
optimize the synthetic routes to key intermediates of molnupiravir and remdesivir to improve
the production of these drugs. We synthesized molnupiravir in 68% overall yield and >99%
purity through two reactions (protection + esterification; functionalization + deprotection)
starting from uridine. Beginning with 1H-pyrrole, we also obtained pyrrolo[2,1-f][1,2,4]triazin4-amine, the N-heteroaromatic core present in the structure of remdesivir, in 85% overall yield
and 98% purity through three reactions (formylation + cyanation, N-amination, and
cyclization). We further established alternative strategies to selectively functionalize the
C-7 position of this N-heterocycle and improved its coupling to D-ribose in the C-glycosylation
step, obtaining a key intermediate in the remdesivir synthetic route in 66% overall yield. Taken
together, these results represent strategic contributions toward synthesizing intermediates of
molnupiravir and remdesivir in a more efficient, practical, and economical manner.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

